News | January 06, 2026
Nia Therapeutics unveils first implantable brain interface for memory disorders
The SNS records neural activity from 60 channels across four brain regions—far exceeding current commercial devices
The SNS records neural activity from 60 channels across four brain regions—far exceeding current commercial devices
IND clearance enables initiation of Phase 1c clinical trial in HFpEF patients with elevated endotrophin levels
Mehta brings strong leadership experience in biopharmaceuticals, life science research, and diagnostics
Gelhaus has a proven track record of driving business growth
Additional data in pregnant adults who are Virologically suppressed reinforce safety and tolerability profile of Biktarvy in broad range of people with HIV
The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19
The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertis
University of Pennsylvania scientists Katalin Karikó and Drew Weissman to be honoured at June 7 symposium in New York City for their research that enabled Covid-19 vaccines
Chandy was the president of the Industrial Division of Pall Corporation, a leading supplier of filtration, separation, and purification technologies. Previously, she was chief marketing officer at the Dow Chemical Company and Rohm and Haas Corporation
The device will facilitate the treatment of cerebral vasospasm following hemorrhagic stroke
Subscribe To Our Newsletter & Stay Updated
